Antimicrobial drug resistance in bacterial pathogens continues, with 1997 s
eeing reports of Staphylococcus aureus no longer fully susceptible to vanco
mycin occurring in the United States. To better deal with this vapidly deve
loping problem, we present the third year of United States national data th
at highlights the geographic nature of increasing resistance to antimicrobi
al agents. In 1997, we observed increasing numbers of vancomycin-resistant
Enterococcus faecium, move methicillin-resistant Staphylococcus aureus (MRS
A), and an apparent spreading of penicillin resistance in pneumococci. The
majority of reporting sites now indicates that over 20% of Pseudomonas aeru
ginosa are fully resistant to ciprofloxacin, the only oral agent available
for treating this pathogen. With increasing resistance coming at a time of
decreasing available resources, it is more clear than ever before that the
future of infections diseases and clinical microbiology remains filled with
challenge. (C) 1999 Elsevier Science Inc.